List of Excipients in API VALGANCICLOVIR HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing VALGANCICLOVIR HYDROCHLORIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 | MANNITOL |
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 | SODIUM BENZOATE |
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 | SUCRALOSE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for VALGANCICLOVIR HYDROCHLORIDE
Excipient focus: .ALPHA.-TOCOPHEROL
VALGANCICLOVIR HYDROCHLORIDE drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACACIA
VALGANCICLOVIR HYDROCHLORIDE drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
VALGANCICLOVIR HYDROCHLORIDE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valganciclovir hydrochloride | 31722-837 |
| American Health Packaging | valganciclovir hydrochloride | 60687-765 |
| NorthStar RxLLC | valganciclovir hydrochloride | 72603-174 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
VALGANCICLOVIR HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
VALGANCICLOVIR HYDROCHLORIDE drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Novadoz Pharmaceuticals LLC | valganciclovir hydrochloride | 72205-019 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
VALGANCICLOVIR HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
VALGANCICLOVIR HYDROCHLORIDE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
VALGANCICLOVIR HYDROCHLORIDE drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
VALGANCICLOVIR HYDROCHLORIDE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
Excipient focus: OCTENYLSUCCINIC ACID
VALGANCICLOVIR HYDROCHLORIDE drug variants containing OCTENYLSUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing OCTENYLSUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
VALGANCICLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
VALGANCICLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
VALGANCICLOVIR HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
VALGANCICLOVIR HYDROCHLORIDE drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
VALGANCICLOVIR HYDROCHLORIDE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
VALGANCICLOVIR HYDROCHLORIDE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| AvKARE | valganciclovir hydrochloride | 42291-972 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
VALGANCICLOVIR HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | valganciclovir hydrochloride powder, | 59651-444 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
VALGANCICLOVIR HYDROCHLORIDE drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| Camber Pharmaceuticals Inc | valganciclovir hydrochloride | 31722-837 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Camber Pharmaceuticals Inc | valganciclovir hydrochloride | 31722-837 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
VALGANCICLOVIR HYDROCHLORIDE drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| AvKARE | valganciclovir hydrochloride | 42291-972 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
VALGANCICLOVIR HYDROCHLORIDE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
VALGANCICLOVIR HYDROCHLORIDE drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| AvKARE | valganciclovir hydrochloride | 42291-972 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Camber Pharmaceuticals Inc | valganciclovir hydrochloride | 31722-837 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
VALGANCICLOVIR HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| AvKARE | valganciclovir hydrochloride | 42291-875 |
| AvKARE | valganciclovir hydrochloride | 42291-973 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
VALGANCICLOVIR HYDROCHLORIDE drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
VALGANCICLOVIR HYDROCHLORIDE drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Par Pharmaceutical | valganciclovir hydrochloride | 0603-6330 |
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
